Skip to main content
Clinical Trials/CTRI/2023/10/058202
CTRI/2023/10/058202
Recruiting
未知

Evaluating the Use of Patient-Reported Outcome Measures for Improving the Inter-RaterReliability of Common Terminology Criteria for Adverse Event Ratings - nil

European Organisation for Research and Treatment of Cancer0 sites0 target enrollmentTBD

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
European Organisation for Research and Treatment of Cancer
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Sponsor
European Organisation for Research and Treatment of Cancer

Eligibility Criteria

Inclusion Criteria

  • 1\.The study population will be adult cancer patients fulfilling the following inclusion criteria: patients
  • aged above 18\.
  • 2\.Any cancer diagnosis (no more than 20% per diagnostic group) current treatment with chemotherapy or immunotherapy inpatient or day clinic setting
  • 3\.Scoring 3 or above on an initial screening question (On a scale of 0 to 10, to what degree did you experience physical or emotional symptoms/problems during the last week? ?).
  • 4\.No severe cognitive impairments written informed consent.
  • Inclusion criteria for physicians performing CTCAE ratings will be at least one year of professional experience in oncology. Chemotherapy has been selected because the EORTC QLQ\-C30 covers common AEs associated with this treatment. Immunotherapy has been added for being an increasingly important treatment option.

Exclusion Criteria

  • There are no exclusion criteria for this study. All types of cancer patients will be enrolled on the study.

Outcomes

Primary Outcomes

Not specified

Similar Trials